Fentanyl case: how Ariel García Furfaro operated to destroy evidence

The judicial investigation established that Ariel García Furfaro, at the head of the pharmaceutical conglomerate Laboratorios Ramallo and HLB Pharma, not only produced and marketed the contaminated fentanyl responsible for 124 deaths, but also led a systematic cover-up plan.

Security videos show private meetings in which García and other executives ordered the destruction of vials, manipulation of records, and falsification of documents to conceal the contamination. According to Judge Kreplak, the clan's strategy included pressuring employees, deleting digital files, and even destroying physical evidence using autoclaves.

The chronology of a tragedy

• December 2024: the batch of adulterated fentanyl is produced.
• January 2025: the product reaches the market.
• April 2025: the first deaths are recorded in hospitals in La Plata.
• May 2025: ANMAT intervenes and the scandal becomes public.
• June 2025: the courts indict García Furfaro, his family, and executives, with multimillion-dollar asset freezes and pretrial detention.

The judge emphasized that Good Manufacturing Practices were systematically violated and that the laboratory had already received previous warnings for similar deficiencies.

The connection with Kirchnerism

The surname Furfaro is not new in Argentine politics. Ariel García Furfaro and his circle had access to Kirchnerist officials during the pandemic, when they tried to act as intermediaries in the importation of the Russian Sputnik V vaccine.

In that context, the clan sought to capitalize on their contacts to position themselves as a strategic supplier to the State. The connection with Kirchnerist figures facilitated bids, rapid authorizations, and a network of political protection that, according to judicial sources, allowed them to expand despite ANMAT's warnings.

Today, with the investigation into the contaminated fentanyl, those connections are once again under scrutiny, since they partly explain the impunity with which the pharmaceutical conglomerate operated.

Indictments and serious charges

In addition to García Furfaro, his mother, Nélida Furfaro (house arrest), his brother Diego (detained), and more than ten executives, including Javier Tchukrán and José Antonio Maiorano, were also indicted.

The main charge is for adulteration of medicinal substances resulting in deaths, with sentences ranging from 10 to 25 years in prison.